Pharma 2020: Marketing the future - Which path will you take? the third in the Pharma 2020 series, outlines a confluence of dynamics that lead to a new marketing and sales system with a smaller, more agile and smarter sales force. The pharma industry is no longer being rewarded for incremental innovation, me-too products and selling the most pills. Companies will need to demonstrate that their brand adds value to patients and they will have to offer a package of products and health services that the market not only wants and needs but is willing to pay a premium for. The paper highlights some very strong facts related to the need for Pharma to change its marketing and sales functions in order to sustain future growth and performance.
This report outlines in some detail what those changes in the business environment will be and provides pharma companies with indicators of organisational and operational structure that could influence their success and readiness to compete.
Axis pharmaceutical is located in Faisalabad also known as Manchester of Pakistan because of its huge Industrial Base specializing in Textiles. The company is owned and run by professionals in the field of Pharmaceuticals having more than 40 years of experience. Our state of the art manufacturing facility is certified GMP compliant and was launched in the year 2009. In a very short span of time; we have started to supply a wide range of different therapeutic classes across the country. Their rapid growth and brand recognition within two years time reflects faith of our clients in our company’s promise of quality. Axis Pharmaceuticals is licensed by the Federal Ministry of Health to manufacture pharmaceutical drugs by the way of formulation.